Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Comparative Within Patient Controlled, Multi-center Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer

NCT05600322 is registered in ClinicalTrials.gov with Photocure as lead sponsor.

NCT NCT05600322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05600322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Comparative Within Patient Controlled, Multi-center Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer
Lead sponsor
Photocure
Phase
Phase 3
Overall status
Completed
Start date
November 3, 2022
Completion date
July 12, 2023
Enrollment
158 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer